Glen Eagle Advisors, LLC Gsk PLC Transaction History

Glen Eagle Advisors, LLC

$546 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$38.5 - $45.78 $80,850 - $96,138	-2,100 Closed	0 $0
Q3 2022 Aug 13, 2024	SELL	$16.13 - $44.61 $32,937 - $91,093	-2,042 Closed	0 $0
Q2 2022 Aug 13, 2024	SELL	$42.05 - $47.77 $462 - $525	-11 Reduced 0.54%	2,042 $88.9 Million
Q1 2022 Aug 13, 2024	BUY	$40.23 - $47.74 $40 - $47	1 Added 0.05%	2,053 $89.4 Million
Q4 2021 Aug 13, 2024	SELL	$38.88 - $45.31 $4,276 - $4,984	-110 Reduced 5.09%	2,052 $90.5 Million
Q3 2021 Aug 13, 2024	BUY	$38.79 - $43.16 $77 - $86	2 Added 0.09%	2,162 $82.6 Million
Q2 2021 Aug 13, 2024	BUY	$36.52 - $41.46 $73 - $82	2 Added 0.09%	2,160 $86 Million
Q1 2021 Aug 13, 2024	BUY	$34.27 - $40.01 $68 - $80	2 Added 0.09%	2,158 $77 Million
Q4 2020 Aug 13, 2024	BUY	$34.07 - $39.94 $73,454 - $86,110	2,156 New	2,156 $79.3 Million
Q3 2020 Aug 13, 2024	BUY	$38.11 - $42.99 $38 - $42	1 Added 0.04%	2,279 $85.8 Million
Q2 2020 Aug 13, 2024	BUY	$37.87 - $43.58 $908 - $1,045	24 Added 1.06%	2,278 $92.9 Million
Q1 2020 Aug 13, 2024	BUY	$32.47 - $48.83 $7,890 - $11,865	243 Added 12.08%	2,254 $85.4 Million
Q4 2019 Aug 13, 2024	BUY	$42.0 - $48.25 $42 - $48	1 Added 0.05%	2,011 $94.5 Million
Q3 2019 Aug 13, 2024	SELL	$40.46 - $43.52 $3,965 - $4,264	-98 Reduced 4.65%	2,010 $85.8 Million
Q2 2019 Aug 13, 2024	BUY	$39.4 - $42.7 $39 - $42	1 Added 0.05%	2,108 $84.4 Million
Q1 2019 Aug 13, 2024	BUY	$38.57 - $42.69 $81,266 - $89,947	2,107 New	2,107 $88 Million
Q4 2018 Aug 13, 2024	BUY	$37.8 - $42.69 $75 - $85	2 Added 0.1%	2,105 $80.4 Million
Q3 2018 Aug 13, 2024	BUY	$39.75 - $42.69 $39 - $42	1 Added 0.05%	2,103 $84.5 Million
Q2 2018 Aug 13, 2024	SELL	$39.61 - $42.76 $2.07 Million - $2.24 Million	-52,346 Reduced 96.14%	2,102 $84.7 Million
Q1 2018 Aug 14, 2024	BUY	$36.18 - $40.15 $75,978 - $84,315	2,100 New	2,100 $82 Million
Q1 2018 Aug 13, 2024	BUY	$36.18 - $40.15 $1.9 Million - $2.11 Million	52,575 Added 2806.99%	54,448 $82 Million
Q4 2017 Aug 13, 2024	BUY	$35.34 - $41.9 $35 - $41	1 Added 0.05%	1,873 $66.5 Million
Q3 2017 Aug 13, 2024	BUY	$39.44 - $41.55 $73,831 - $77,781	1,872 New	1,872 $76 Million
Q4 2016 Aug 12, 2024	BUY	N/A	600	600 $23.1 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

175K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $75.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Account